Browse

Targeted therapy of DNA tumor virus-associated cancers using virus-activated transcription factors

Cited 20 time in Web of Science Cited 24 time in Scopus
Authors
Lim, Mi Jung; Min, Sang-Hyun; Lee, Jae-Jung; Kim, Il Chul; Kim, Ji Tae; Lee, Dong Chul; Kim, Nam-Soon; Jeong, Sangkyun; Kim, Mi Na; Kim, Kwang Dong; Lim, Jong-Seok; Han, Sang Bae; Kim, Hwan Mook; Heo, Dae Seog; Yeom, Young Il
Issue Date
2006-02-08
Publisher
Elsevier
Citation
Mol Ther. 2006 May;13(5):899-909. Epub 2006 Feb 3.
Keywords
Adenoviridae/geneticsAnimalsCOS CellsCell Line, TransformedCell Line, TumorCell Transformation, ViralCercopithecus aethiopsDNA Tumor Viruses/*geneticsE2F Transcription Factors/genetics/metabolismFemale*Gene TherapyHela CellsHumansMiceMice, Inbred C57BLNFI Transcription Factors/genetics/metabolismNIH 3T3 CellsNeoplasms/genetics/*therapy/virologySp1 Transcription Factor/genetics/metabolismTranscription Factors/*genetics/*metabolismXenograft Model Antitumor Assays
Abstract
DNA tumor virus-mediated tumorigenic processes typically involve functional inactivation of cellular tumor suppressors pRB and p53 by viral oncoproteins, with concomitant activation of oncogenic transcription factors such as E2Fs. This feature could be exploited to design a treatment for corresponding malignancies. Here, we report a gene therapy strategy for DNA tumor virus-associated cancers using a synthetic, E2F-regulated gene expression system named pESM6. This system contains multimerized E2F-responsive elements in combination with the binding sites for ubiquitous transcription factors Sp1 and CTF/NF1. pESM6 could drive a high-level transgene expression comparable to that of the CMV IE promoter and exert constitutive activity in cells expressing DNA tumor viral oncogenes. In contrast, it was effectively repressed by pRB and thus only minimally active in nontransformed cells. Expression of cytosine deaminase from pESM6 resulted in a highly efficient and specific killing of HPV-transformed fibroblasts (C3) after treatment with the prodrug 5-fluorocytosine. Also, an effective tumor mass reduction was observed when the vector was injected directly into C3 tumors implanted in C57BL/6 mice. pESM6 showed a superior performance throughout these experiments compared to the previously known E2F-regulated gene vector. These results clearly demonstrate the potential usability of pESM6 for the gene therapy of DNA tumor virus-associated cancers.
ISSN
1525-0016 (Print)
Language
English
URI
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16461008

http://hdl.handle.net/10371/47156
DOI
https://doi.org/10.1016/j.ymthe.2005.11.023
Files in This Item:
There are no files associated with this item.
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Molecular and Clinical Oncology (분자종양의학전공)Journal Papers (저널논문_분자종양의학전공)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse